Summary by Moomoo AI
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.